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We prospectively studied 64 consecutive patients on whom computerized tomography-guided fine needle aspirations
(CT-FNA) of pulmonary lesions were performed to determine whether obtaining a delayed chest radiograpy (CXR)
after CT-FNA is helpful in the diagnosis of post-procedure pneumothorax (PTX). Two of the 64 patients developed
a delayed PTX. Only one of the patients with a delayed PTX required chest tube drainage. If patients have no
evidence of a PTX immediately after a CT-FNA by CT scan then a delayed CXR adds little to care of these patients.
RESPIR. MED. (1999) 93, 379–381Introduction
Computerized tomography-guided transthoracic fine needle
aspiration (CT-FNA) is an eVective, simple, and accurate
diagnostic method for the evaluation of pulmonary lesions.
Adequate samples of tissue can be obtained in 74–100% of
CT-FNA of pulmonary lesions with a diagnostic accuracy
of 81–99% (1–3). This procedure is of relatively low cost
with acceptable risks for mortality and morbidity.
Pneumothorax (PTX) is the most common complication
of CT-FNA of pulmonary lesions. The reported incidence
of PTX as a complication of CT-FNA of pulmonary lesions
varies widely from 8–61% (1,4–6). However, it is not known
how often PTX presents immediately following the pro-
cedure or as a late complication. The operator’s concern
about potential delayed PTX development has lead some
clinicians to order post-procedure chest radiographs
(CXR). This practice has not been determined to be
necessary or cost-eVective.Materials and Methods
With Institutional Review Board approval, 64 consecutive
patients who were to have CT-FNA of a pulmonary lesion
were oVered inclusion and agreed to participate in this
prospective study.0954-6111/99/060379+03 $12.00/0A 22-gauge Chiba needle (Boston Scientific Corporation,
Waterton, MA, U.S.A.) was used for aspirating the pul-
monary lesions in all cases. Cytological examination of
obtained material was carried out immediately to determine
if additional aspiration attempts were necessary. After
completion of CT-FNA each patient was re-imaged with
two addional views with the CT scanner (Picker PQ 2000,
Cleveland, Ohio, U.S.A.) to check for PTX. An expiratory
CXR was obtained on each patient 4 h later. The percent-
age of patients who developed a PTX, the size of the PTX,
whether it was identifiable immediately or was delayed, and
what intervention, if any, was undertaken were recorded.
When intervention was clinically indicated a small bore
catheter (Arrow International, Reading, PA, U.S.A.) was
placed anteriorly into the second intercostal space. All
patients requiring chest tube insertion were admitted to the
hospital.
The patient’s age, sex, and the degree of obstructive lung
disease as measured by pulmonary function testing were
recorded. The position of the patient (prone, supine, or
lateral decubitus) at the time of biopsy, the lobe of the lung
in which the lesion was located, the number of needle passes
taken into the each lesion, the depth of needle penetration,
and the size of the pulmonary lesions were also obtained.Received 15 October and accepted 19 January 1999.
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(423) 461-7939.Statistical Analysis
DiVerences between the patients that developed PTX and
those that did not were analysed statistically by performing
the two-sample t-test. DiVerences in the frequencies of
dichotomous parameters were analysed by Pearson’s
chi-square analysis. A P-value of 0.05 was accepted as
statistically significant.? 1999 W. B. SAUNDERS COMPANY LTD
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All patients were male with a mean age of 67&8 years.
Thirteen of the 64 patients (20%) developed a PTX (Table
1). Eleven (85%) of the PTXs were noted immediately with
post-procedure CT imaging. Chest tubes were placed in
three patients who experienced shortness of breath and/or
chest pain. PTX was delayed and identified on post-
procedure expiratory CXR in two patients (3·1%). One of
the patients with a delayed PTX required intervention
(1·5%).
There was no statistically significant diVerence between
the patients that did and did not develop a PTX with
respect to age, the lobe of the lung sampled, the position of
the patient at the time of biopsy, the depth of needle
penetration, or the number of needle passes (Table 2 and 3).
Forty-one of the 64 patients (64%) had documented chronic
obstructive pulmonary disease (COPD) of varying severity.
Although there was no significant diVerence in the degree of
COPD between the patients who did and did not develop
PTX, all the patients that required chest tube intervention
had severe to very severe obstructive airway disease [forced
expiratory volume in 1 s (FEV
1
) less than 50% of predicted].
Due to the small number of PTX, a larger sample size may
be necessary to test the reliability of this observation.
The size of the parenchymal lesion was the only factor
that was statistically diVerrent between those patients who
did and did not develop a PTX. Those patients that
suVerred a PTX typically had a smaller pulmonary lesion
(P=0·02).Table 1. Development of PTX following CT-FNA
Total patients (n) 64
No PTX (n) 51
PTX (n) 13
Immediate PTX 11
No intervention 8
Intervention 3
Delayed PTX 2
No intervention 1
Intervention 1Table 2. Statistical analysis comparing patients who did and did not develop PTX following
CT-FNA using the two-sample t-test
Patients undergoing CT-FNA
(n=64)
No PTX
(n=51)
(mean&sd)
PTX
(n=13)
(mean&sd)
Statistical
significance
Age (years) 68·5&7·5 65·5&9·3 n.s.*
Depth of needle penetration (cm) 5·5&1·5 5·7&1·5 n.s.
Number of needle passes (cm) 1·7&0·7 1·9&0·6 n.s.
Lesion size (cm) 3·7&2·5 2·6&1·2 P=0·02
*n.s.=no significant diVerence.Table 3. Statistical analysis comparing patients who
did and did not develop PTX following CT-FNA using
Pearson’s chi-square test
Statistical
significance
Lobe of lung involved n.s.*
Position of patient n.s.
Degree of COPD n.s.
*n.s.=no significant diVerence.Discussion
The leading cause of iatrogenic PTX is transthoracic needle
aspiration of pulmonary lesions (7,8) The reported inci-
dence in general falls into the 40% range (1,3,6,9,10). The
reason our patients experienced a lower number of PTXs
(20%) is not clear but may be related to the size of the
lesions that were sampled. Chest-tube intervention for
FNA-induced PTX is reported to be necessary in 2–21% of
cases (3,6,10,11). Four of our 64 patients (6%) required
chest-tube drainage, which is consistent with this
observation.
Patients with obstructive lung disease appear to have a
higher rate of PTX following CT-FNA when compared to
patients with normal lung function (11–13). Other authors
suggest that it is not the degree of measured airflow
obstruction but the alveolar hyperinflation associated with
bronchial obstruction that increases the risk (10,14). Still
other authors argue that the degree of COPD does not
contribute to the development of a FNA-associated PTX
but that chest-tube placement is needed more frequently in
patients with obstructive lung disease (6,9). While there was
no significant diVerence between our patients who did and
did not develop PTX, our data suggest that chest-tube
intervention is more likely to be necessary in patients with
severe degrees of airway obstruction.
The depth of needle penetration required to sample a
pulmonary lesion has been demonstrated to be a significant
predictor of the occurrence of PTX (6,10). The increased
frequency of PTX may be due to the crossing of additional
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with deep penetration the needle may be less stable with
respiratory movements causing greater stresses at the point
of entry into the thorax. When a CT-FNA needle does not
traverse aerated lung the likelihood of PTX is also
decreased (5).
The size of the lesion undergoing CT-guided FNA was a
significant risk factor for PTX in our population. This
observation has been previously demonstrated (6,9). The
reasons that a small lesion may be a risk factor for PTX
include a diminished ability to obtain adequate tissue
necessitating multiple needle passes with multiple pleural
interruptions. Similarly, larger parenchymal lesions may
more closely approximate the chest wall by their size,
decreasing the required depth of needle penetration. While
not statistically significant, our data show that a higher
number of needle passes and deeper needle penetration
were required in patients with smaller lesions who
developed PTX.
Positioning the patient into the lateral decubitus position
has been shown not to alter the rate of post-FNA PTX or
the proportion of patients who will require intervention for
this complication (15). Our data confirm this observation.
In addition, there was no diVerence in PTX rate when
patients were placed in the prone or supine position or in
consideration of what lobe of the lung was biopsied.
While treatment of the post-biopsy PTX has traditionally
been with large-bore (22–32 French) chest tubes, small
catheters are less traumatic and troublesome than the large
intercostal chest-tube drainage (16). Small-caliber inter-
costal catheters (8 French) were used successfully in each of
the four patients who required drainage of their PTX. This
reinforces the previously reported observations that small-
bore percutaneous catheters can eVectively and easily treat
post-biopsy PTX (16,17).
The practice of obtaining a delayed post-procedure CXR
after CT-FNA is not an eYcient use of resources or the
patient’s time. CXR imaging adds little information regard-
ing lung expansion to that obtained by CT at the end of the
CT-FNA. In our study, the risk of missing a PTX which
required intervention by omitting delayed CXR imaging
was less than 2%. Patient instruction to seek medical
attention in the event of symptoms of PTX would be a more
eVective method of addressing this potential complication.References
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